CIP
CRL icon

Capital Insight Partners’s Charles River Laboratories CRL Stock Holding History

Capital Insight Partners’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,239
Closed -$2.27M – 174
2023
Q1 		$2.27M Buy
11,239
+198
+2% +$44.9K 0.53% 66
2022
Q4 		$2.41M Buy
11,041
+136
+1% +$29.7K 0.62% 57
2022
Q3 		$2.15M Buy
10,905
+80
+0.7% +$17.3K 0.58% 60
2022
Q2 		$2.32M Buy
10,825
+503
+5% +$123K 0.54% 62
2022
Q1 		$2.93M Buy
10,322
+1,048
+11% +$323K 0.6% 58
2021
Q4 		$3.49M Buy
9,274
+933
+11% +$362K 0.71% 49
2021
Q3 		$3.44M Sell
8,341
-177
-2% -$73.5K 0.75% 42
2021
Q2 		$3.15M Buy
8,518
+6
+0.1% +$2K 0.71% 47
2021
Q1 		$2.47M Sell
8,512
-34
-0.4% -$9.45K 0.6% 65
2020
Q4 		$2.13M Sell
8,546
-11
-0.1% -$2.62K 0.54% 72
2020
Q3 		$1.94M Sell
8,557
-4
-0% -$830 0.54% 68
2020
Q2 		$1.49M Sell
8,561
-80
-0.9% -$12.8K 0.47% 76
2020
Q1 		$1.09M Buy
8,641
+749
+9% +$112K 0.58% 59
2019
Q4 		$1.21M Buy
7,892
+172
+2% +$23.8K 0.55% 54
2019
Q3 		$1.02M Buy
7,720
+57
+0.7% +$7.64K 0.89% 51
2019
Q2 		$1.09M Buy
+7,663
New +$1.04M 0.94% 49

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Capital Insight Partners's CRL Position: Q2 2023 in Review

Capital Insight Partners sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 11,239 shares — an estimated $2.27M sold.

Capital Insight Partners first reported a position in CRL in Q2 2019 and held it in 16 quarters. The position peaked at $3.49M in Q4 2021. 611 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Capital Insight Partners reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Capital Insight Partners sold 11,239 Charles River Laboratories shares in Q2 2023, an estimated $2.27M.
  • Capital Insight Partners first reported a position in Charles River Laboratories in Q2 2019 and held it in 16 quarters.
  • Capital Insight Partners's Charles River Laboratories position peaked at $3.49M in Q4 2021.
  • 611 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Capital Insight Partners's 13F filing for Q2 2023, filed 24 Jul 2023.